Caption Management, LLC Neurocrine Biosciences Inc Put Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $3.9 Million - $4.3 Million	-29,900 Reduced 54.46%	25,000 $3.45 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $2.38 Million - $2.97 Million	22,400 Added 68.92%	54,900 $7.23 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $235,050 - $292,750	2,500 Added 8.33%	32,500 $3.66 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $941,100 - $1.23 Million	10,000 Added 50.0%	30,000 $3.04 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $2.13 Million - $2.54 Million	20,000 New	20,000 $2.39 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $6.44 Million - $8.51 Million	-85,000 Reduced 60.71%	55,000 $5.36 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $5.8 Million - $7.58 Million	80,000 Added 133.33%	140,000 $13.1 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $2.39 Million - $3.19 Million	-30,000 Reduced 33.33%	60,000 $5.11 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $2.59 Million - $2.97 Million	30,000 Added 50.0%	90,000 $8.63 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $1.79 Million - $2.05 Million	-20,000 Reduced 25.0%	60,000 $5.84 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $956,010 - $1.19 Million	11,000 Added 15.94%	80,000 $7.67 Million
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $3.75 Million - $5.27 Million	39,000 Added 130.0%	69,000 $6.64 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $375,550 - $568,800	5,000 Added 20.0%	30,000 $2.6 Million
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $2.17 Million - $2.96 Million	25,000 New	25,000 $2.69 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $2.51 Million - $3.05 Million	-30,000 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$72.24 - $91.27 $3.97 Million - $5.02 Million	-55,000 Reduced 64.71%	30,000 $2.53 Million
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $5.89 Million - $7.78 Million	85,000 New	85,000 $7.49 Million

Others Institutions Holding NBIX

# of Institutions

632

Shares Held

93.9M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.43 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$738 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$369 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$267 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account